MwanzoIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Bei iliyotangulia
$ 72.88
Bei za siku
$ 71.48 - $ 74.72
Bei za mwaka
$ 23.95 - $ 75.49
Thamani ya kampuni katika soko
12.06B USD
Wastani wa hisa zilizouzwa
2.07M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 156.72M | 17.12% |
Matumizi ya uendeshaji wa biashara | 96.81M | 57.06% |
Mapato halisi | -128.61M | 8.45% |
Kiwango cha faida halisi | -82.06 | 21.83% |
Mapato kwa kila hisa | -0.61 | 15.49% |
EBITDA | -157.31M | -7.98% |
Asilimia ya kodi ya mapato | -0.17% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.24B | -9.94% |
Jumla ya mali | 3.03B | -1.56% |
Jumla ya dhima | 2.42B | -0.14% |
Jumla ya hisa | 617.97M | — |
hisa zilizosalia | 161.97M | — |
Uwiano wa bei na thamani | 18.98 | — |
Faida inayotokana na mali | -13.31% | — |
Faida inayotokana mtaji | -15.13% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -128.61M | 8.45% |
Pesa kutokana na shughuli | -131.44M | -14.30% |
Pesa kutokana na uwekezaji | 91.34M | 126.80% |
Pesa kutokana na ufadhili | 81.22M | -83.63% |
Mabadiliko halisi ya pesa taslimu | 41.04M | 1.05% |
Mtiririko huru wa pesa | -71.55M | -55.03% |
Kuhusu
Ionis Pharmaceuticals, Inc. is a biotechnology that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1989
Makao Makuu
Tovuti
Wafanyakazi
1,069
